Diagnosis and treatment

FILE - In this Jan. 17, 2019, file photo, a sign with the Sackler name is displayed at the Metropolitan Museum of Art in New York. Their name used to be on a wing at the Louvre. But now the Sackler family wealth has become linked to sales of OxyContin, and their company, drug maker Purdue Pharma, is attempting to settle lawsuits over the opioid crisis. (AP Photo/Seth Wenig, File)
September 19, 2019 - 5:24 pm

Who are the Sacklers, the family behind maker of OxyContin?

For a family with its name on a wing of one of the world's most famous museums and a school at a prestigious university, members of the Sackler clan have done a remarkable job of vanishing from public life. The family owns OxyContin maker Purdue Pharma, which filed for bankruptcy this week as part...
Read More
Speaker of the House Nancy Pelosi, D-Calif., arrives for a closed-door meeting with the House Democratic Caucus, Wednesday, Sept. 18, 2019, at the Capitol in Washington. (AP Photo/J. Scott Applewhite)
AP Newsroom
September 19, 2019 - 4:05 pm

Nancy Pelosi unveils an ambitious plan to lower drug prices

WASHINGTON (AP) — House Speaker Nancy Pelosi, trying to seize the agenda on a leading consumer issue, announced an ambitious prescription drug plan Thursday that would allow Medicare to negotiate prices for seniors and younger people. The proposal would direct Medicare to bargain over as many as...
Read More
September 19, 2019 - 11:20 am

US awards $3M to fill gaps in medical marijuana research

The U.S. government will spend $3 million to find out if marijuana can relieve pain, but none of the money will be used to study the part of the plant that gets people high. Nine research grants announced Thursday are for work on CBD, the trendy ingredient showing up in cosmetics and foods, and...
Read More
FILE - In this Nov. 5, 2018 file photo, a drugstore employee reaches for medicine from shelf in downtown Tehran, Iran. A cheap, daily pill that combines four drugs has been tested for the first time in the United States to see if it works as well among low-income Americans as it has in other countries to treat conditions leading to heart attacks and strokes. The results published Wednesday, Sept. 18, 2019, suggest the combo pill can lower blood pressure and bad cholesterol. Experts say the study may draw U.S. interest to a strategy that has been seen as useful only in places with limited access to medical care. (AP Photo/Ebrahim Noroozi, File)
September 18, 2019 - 6:45 pm

Will combo pill catch on in US to prevent heart attacks?

A cheap, daily pill that combines four drugs has been tested for the first time in the United States to see if it works as well among low-income Americans as it has in other countries to treat conditions leading to heart attacks and strokes. Experts said the study may draw U.S. interest to a...
Read More
FILE - In this Thursday, Sept. 12, 2019 file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. The allegations surrounding wealthy donors such as the Sackler family have raised questions for the museums they supported, including whether to keep the family's name on prominent galleries. The billionaire family is notorious for its ties to the drug company Purdue Pharma, which developed OxyContin, a painkiller that has been at the center of the opioid crisis. (AP Photo/Frank Franklin II, File)
September 18, 2019 - 1:13 am

Sackler money complicates donation policies for museums

NEW YORK (AP) — Ask the CEO and president of the Metropolitan Museum of Art whether he's accepting money from the Sacklers, the billionaire dynasty notorious for its ties to the drug company Purdue Pharma, and the answer is somewhat complicated. For one thing, it depends on which Sackler. "There...
Read More
FILE - This May 8, 2007, file photo shows the Purdue Pharma logo at its offices in Stamford, Conn. (AP Photo/Douglas Healey, File)
AP Newsroom
September 17, 2019 - 5:24 pm

Purdue Pharma to stay in business as bankruptcy unfolds

WHITE PLAINS, N.Y. (AP) — A judge cleared the way Tuesday for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed against it in a reckoning over the opioid crisis. At the first court hearing since the Chapter 11...
Read More
AP Newsroom
September 17, 2019 - 9:39 am

Alex Trebek shares unfortunate personal news

NEW YORK (AP) — "Jeopardy!" host Alex Trebek says he's had a setback in his battle with pancreatic cancer and is undergoing chemotherapy again. Trebek told ABC's "Good Morning America" on Tuesday that after a short period of optimism when he stopped chemotherapy, his "numbers shot up" and doctors...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 16, 2019 - 8:07 am

After bankruptcy filing, Purdue Pharma may not be off hook

OxyContin maker Purdue Pharma and its owners expressed sympathy but not responsibility for the nation's opioid crisis as the company filed for bankruptcy protection late Sunday night, part of a move to settle some 2,600 lawsuits — most from state and local governments. "Like families across America...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 15, 2019 - 11:46 pm

Purdue Pharma files for bankruptcy as part of settlement

Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy in White Plains, New York, days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids. The filing was anticipated before...
Read More
Cars pass Purdue Pharma headquarters Thursday, Sept. 12, 2019, in Stamford, Conn. For months, the judge overseeing national litigation over the opioids crisis urged all sides to reach a settlement that could end thousands of lawsuits filed by state and local governments. But the chaotic developments this week in the case against OxyContin maker Purdue Pharma underscore how difficult that goal is. (AP Photo/Frank Franklin II)
September 13, 2019 - 11:11 pm

NY finds $1B in hidden transfers by family behind OxyContin

NEW YORK (AP) — The family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion to themselves, New York's attorney general contends in court papers filed Friday. New York — asking a judge to enforce subpoenas of companies, banks and advisers to Purdue...
Read More

Pages